Liudmila Polonchuk.

Cell Rep Med · 2022

expert_opinion · Level V

Where this comes from

Abstract

Together with a group of academic and industrial experts, Liudmila Polonchuk proposes real-world data as a novel source to quantify pro-arrhythmic risk for translation of preclinical cardiac safety data to humans in a new upcoming regulatory paradigm aiming to advance drug candidates with maximum benefits and minimal risks for patients.

Medical subject headings